3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
5
Head and Neck Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Multiple Myeloma
3
Lymphoma
3
Stomach Neoplasms
2
Pancreatic Neoplasms
2
Neoplasms
2
Neoplasm Metastasis
2
Melanoma
2
Lung Neoplasms
2
Hematologic Neoplasms
2
Esophageal Neoplasms
2
Colorectal Neoplasms
2
Colonic Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Squamous Cell Cancers of the Head and Neck
1
Skin Neoplasms
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Ovarian Neoplasms
1
NSCLC Harboring NRG1 Fusion
1
Mouth Neoplasms
1
Glioma
1
Fanconi Anemia
1
Endometrial Neoplasms
1
Cholangiocarcinoma
1
Interventions
pembrolizumab
5
Nivolumab
3
Cisplatin
3
Taxes
2
Paclitaxel
2
poly ICLC
1
fludarabine phosphate
1
fludarabine
1
abemaciclib
1
Risk Factors
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy
1
Radiation
1
Pemetrexed
1
Nimorazole
1
Injections
1
High-Intensity Focused Ultrasound Ablation
1
Erlotinib Hydrochloride
1
Docetaxel
1
Cyclophosphamide
1
Cetuximab
1
Carboplatin
1
Biological Products
1
Bevacizumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms, Squamous Cell
×
Afatinib
×
1 year
×
Clear all
No trials found.